Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas

被引:93
作者
Chuman, Y
Bergman, AC
Ueno, T
Saito, S
Sakaguchi, K
Alaiya, AA
Franzén, B
Bergman, T
Arnott, D
Auer, G
Appella, E
Jörnvall, H
Linder, S
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden
[2] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA
[3] Radiumhemmets Res Lab, Stockholm, Sweden
[4] Karolinska Hosp, Unit Tumor Pathol, Canc Ctr Karolinska, Dept Pathol & Oncol, S-17176 Stockholm, Sweden
[5] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA
关键词
lung adenocarcinoma; aspartic protease; tumor diagnosis; mass spectrometry;
D O I
10.1016/S0014-5793(99)01493-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A pair of 35 kDa polypeptides (TAO1/TAO2) are expressed in more than 90% of all primary lung adenocarcinomas but not in other major malignancies. Mass spectrometry of tryptic peptides showed that TAO1/TAO2 is identical to napsin A, a recently described member of the aspartic proteinase family. The site of processing of pronapsin A to the mature form was located, Napsin expression was detected in human lung adenocarcinoma tumors, compatible with the marker nature of TAO1/TAO2 in the diagnosis of primary lung adenocarcinoma. This is important since identification of markers which can distinguish primary lung adenocarcinomas from distant metastases is desirable. Northern blot analysis showed expression of napsin also in normal lung and kidney tissue, and in situ hybridization showed expression in type II alveolar cells of the lung. This protease is concluded to have a specific functional role in the normal alveolar epithelium and is a candidate protease for the proteolytic processing of surfactant precursors. (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 17 条
[1]  
[Anonymous], 1982, AM J CLIN PATHOL, V77, P123
[2]   An integrated approach to proteome analysis: Identification of proteins associated with cardiac hypertrophy [J].
Arnott, D ;
O'Connell, KL ;
King, KL ;
Stults, JT .
ANALYTICAL BIOCHEMISTRY, 1998, 258 (01) :1-18
[3]  
BERGMAN AC, 1999, IN PRESS ELECTROPHOR
[4]   Prostate-specific antigen and new related markers for prostate cancer [J].
Daher, R ;
Beaini, M .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (09) :671-681
[5]   NONENZYMATIC EXTRACTION OF CELLS FROM CLINICAL TUMOR MATERIAL FOR ANALYSIS OF GENE-EXPRESSION BY 2-DIMENSIONAL POLYACRYLAMIDE-GEL ELECTROPHORESIS [J].
FRANZEN, B ;
LINDER, S ;
OKUZAWA, K ;
KATO, H ;
AUER, G .
ELECTROPHORESIS, 1993, 14 (10) :1045-1053
[6]   DETECTION OF POLYPEPTIDES ASSOCIATED WITH THE HISTOPATHOLOGICAL DIFFERENTIATION OF PRIMARY LUNG-CARCINOMA [J].
HIRANO, T ;
FRANZEN, B ;
URYU, K ;
OKUZAWA, K ;
ALAIYA, AA ;
VANKY, F ;
RODRIGUES, L ;
EBIHARA, Y ;
KATO, H ;
AUER, G .
BRITISH JOURNAL OF CANCER, 1995, 72 (04) :840-848
[7]   Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features [J].
Hirano, T ;
Fujioka, K ;
Franzen, B ;
Okuzawa, K ;
Uryu, K ;
Shibanuma, H ;
Numata, K ;
Konaka, C ;
Ebihara, Y ;
Takahashi, M ;
Kato, H ;
Auer, G .
BRITISH JOURNAL OF CANCER, 1997, 75 (07) :978-985
[8]   Monoclonal antibody to thyroid transcription factor-1: Production, characterization, and usefulness in tumor diagnosis [J].
Holzinger, A ;
Dingle, S ;
Bejarano, PA ;
Miller, MA ;
Weaver, TE ;
DiLauro, R ;
Whitsett, JA .
HYBRIDOMA, 1996, 15 (01) :49-53
[9]   Molecular structures and interactions of pulmonary surfactant components [J].
Johansson, J ;
Curstedt, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 244 (03) :675-693
[10]  
Linnoila R I, 1992, J Natl Cancer Inst Monogr, P61